MedPath

Vasculera

Product InformationVASCULERA Tablets for oral administration.Dispensed by prescription.diosmiplex 630mg

Approved
Approval ID

563d3d34-a547-471e-aecd-f4a4a57cbf1d

Product Type

MEDICAL FOOD

Effective Date

Feb 24, 2025

Manufacturers
FDA

Primus Pharmaceuticals, Inc.

DUNS: 130834745

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

diosmiplex

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68040-610
Product Classification
G
Generic Name
diosmiplex
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 24, 2025
FDA Product Classification

INGREDIENTS (9)

DIOSMINActive
Quantity: 600 mg in 1 1
Code: 7QM776WJ5N
Classification: ACTIB
CALCIUM MAGNESIUM POTASSIUM CARBONATE CHLORIDE HYDROXIDEInactive
Code: Z7R65IFU98
Classification: CNTM
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
OPADRY YS-1-17274A BEIGEInactive
Code: UP4CT4IW2C
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vasculera - FDA Drug Approval Details